Literature DB >> 22496238

Structural insight into the unique properties of adeno-associated virus serotype 9.

Michael A DiMattia1, Hyun-Joo Nam, Kim Van Vliet, Matthew Mitchell, Antonette Bennett, Brittney L Gurda, Robert McKenna, Norman H Olson, Robert S Sinkovits, Mark Potter, Barry J Byrne, George Aslanidi, Sergei Zolotukhin, Nicholas Muzyczka, Timothy S Baker, Mavis Agbandje-McKenna.   

Abstract

Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for cardiac muscle and the ability to cross the blood-brain barrier compared to other AAV serotypes. To help identify the structural features facilitating these properties, we have used cryo-electron microscopy (cryo-EM) and three-dimensional image reconstruction (cryo-reconstruction) and X-ray crystallography to determine the structure of the AAV9 capsid at 9.7- and 2.8-Å resolutions, respectively. The AAV9 capsid exhibits the surface topology conserved in all AAVs: depressions at each icosahedral two-fold symmetry axis and surrounding each five-fold axis, three separate protrusions surrounding each three-fold axis, and a channel at each five-fold axis. The AAV9 viral protein (VP) has a conserved core structure, consisting of an eight-stranded, β-barrel motif and the αA helix, which are present in all parvovirus structures. The AAV9 VP differs in nine variable surface regions (VR-I to -IX) compared to AAV4, but at only three (VR-I, VR-II, and VR-IV) compared to AAV2 and AAV8. VR-I differences modify the raised region of the capsid surface between the two-fold and five-fold depressions. The VR-IV difference produces smaller three-fold protrusions in AAV9 that are less "pointed" than AAV2 and AAV8. Significantly, residues in the AAV9 VRs have been identified as important determinants of cellular tropism and transduction and dictate its antigenic diversity from AAV2. Hence, the AAV9 VRs likely confer the unique infection phenotypes of this serotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496238      PMCID: PMC3393551          DOI: 10.1128/JVI.07232-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy.

Authors:  Peter B Rosenthal; Richard Henderson
Journal:  J Mol Biol       Date:  2003-10-31       Impact factor: 5.469

2.  Assessment of phase accuracy by cross validation: the free R value. Methods and applications.

Authors:  A T Brünger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-01-01

3.  Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.

Authors:  T Vandendriessche; L Thorrez; A Acosta-Sanchez; I Petrus; L Wang; L Ma; L DE Waele; Y Iwasaki; V Gillijns; J M Wilson; D Collen; M K L Chuah
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

4.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

5.  Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

Authors:  Roberto Calcedo; Luk H Vandenberghe; Guangping Gao; Jianping Lin; James M Wilson
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

6.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6).

Authors:  Qing Xie; Thomas F Lerch; Nancy L Meyer; Michael S Chapman
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

8.  Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.

Authors:  Ciaran D Scallan; Haiyan Jiang; Tongyao Liu; Susannah Patarroyo-White; Jurg M Sommer; Shangzhen Zhou; Linda B Couto; Glenn F Pierce
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

9.  Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.

Authors:  M K L Chuah; T Vandendriessche
Journal:  Bull Mem Acad R Med Belg       Date:  2007

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  88 in total

1.  Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.

Authors:  Sanford L Boye; Antonette Bennett; Miranda L Scalabrino; K Tyler McCullough; Kim Van Vliet; Shreyasi Choudhury; Qing Ruan; James Peterson; Mavis Agbandje-McKenna; Shannon E Boye
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 2.  The potential of adeno-associated viral vectors for gene delivery to muscle tissue.

Authors:  Dan Wang; Li Zhong; M Abu Nahid; Guangping Gao
Journal:  Expert Opin Drug Deliv       Date:  2014-01-03       Impact factor: 6.648

3.  Structural insights into adeno-associated virus serotype 5.

Authors:  Lakshmanan Govindasamy; Michael A DiMattia; Brittney L Gurda; Sujata Halder; Robert McKenna; John A Chiorini; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

4.  Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.

Authors:  Shen Shen; Garrett E Berry; Ruth M Castellanos Rivera; Roland Y Cheung; Andrew N Troupes; Sarah M Brown; Tal Kafri; Aravind Asokan
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

Review 5.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

6.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

Review 7.  Engineering adeno-associated viruses for clinical gene therapy.

Authors:  Melissa A Kotterman; David V Schaffer
Journal:  Nat Rev Genet       Date:  2014-05-20       Impact factor: 53.242

8.  AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart.

Authors:  Xiufang Pan; Yongping Yue; Keqing Zhang; Chady H Hakim; Kasun Kodippili; Thomas McDonald; Dongsheng Duan
Journal:  Hum Gene Ther Methods       Date:  2015-04-01       Impact factor: 2.396

9.  Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.

Authors:  Balasubramanian Venkatakrishnan; Joseph Yarbrough; John Domsic; Antonette Bennett; Brian Bothner; Olga G Kozyreva; R Jude Samulski; Nicholas Muzyczka; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

10.  Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.

Authors:  Lauren M Drouin; Bridget Lins; Maria Janssen; Antonette Bennett; Paul Chipman; Robert McKenna; Weijun Chen; Nicholas Muzyczka; Giovanni Cardone; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.